{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T01:25:42Z","timestamp":1755221142882,"version":"3.43.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.curtheres.2024.100767","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T19:38:27Z","timestamp":1733168307000},"page":"100767","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Oral Cyclosporine Treatment for Four Pediatric Patients With Toxic Epidermal Necrolysis That Showed No Response to High-dose Corticosteroids in Combination With Intravenous Immunoglobulin: A Case Series"],"prefix":"10.1016","volume":"102","author":[{"given":"Peijing","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5634-9314","authenticated-orcid":false,"given":"Xipeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.curtheres.2024.100767_bib0001","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s12016-021-08859-0","article-title":"Current perspectives on severe drug eruption","volume":"61","author":"Zhang","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"issue":"7","key":"10.1016\/j.curtheres.2024.100767_bib0002","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.jid.2016.03.023","article-title":"Morbidity and mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis in United States adults","volume":"136","author":"Hsu","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100767_bib0003","first-page":"94","article-title":"Syndromes de Stevens-Johnson et de Lyell: \u00e9tude de 185 cas au CHU de Treichville (Abidjan, C\u00f4te d'Ivoire) [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (C\u00f4te d'Ivoire)]","volume":"24","author":"Kourouma","year":"2014","journal-title":"Med Sante Trop"},{"key":"10.1016\/j.curtheres.2024.100767_bib0004","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.4103\/jfmpc.jfmpc_1162_23","article-title":"A case of Stevens-Johnson syndrome treated with oral cyclosporine","volume":"12","author":"Griffith","year":"2023","journal-title":"J Family Med Prim Care"},{"key":"10.1016\/j.curtheres.2024.100767_bib0005","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/pde.13236","article-title":"Successful use of cyclosporin A for Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in three children","volume":"34","author":"St. John","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.curtheres.2024.100767_bib0006","doi-asserted-by":"crossref","first-page":"11622","DOI":"10.4103\/idoj.IDOJ_326_20","article-title":"Cyclosporine in Stevens Johnson syndrome and toxic epidermal necrolysis: experience from a tertiary care centre of South Rajasthan","volume":"12","author":"Balai","year":"2021","journal-title":"Indian Dermatol Online J"},{"year":"2012","series-title":"Dermatology","author":"Bolognia","key":"10.1016\/j.curtheres.2024.100767_bib0007"},{"issue":"600","key":"10.1016\/j.curtheres.2024.100767_bib0008","doi-asserted-by":"crossref","first-page":"eaax2398","DOI":"10.1126\/scitranslmed.aax2398","article-title":"Neutrophils initiate and exacerbate Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"13","author":"Kinoshita","year":"2021","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.curtheres.2024.100767_bib0009","doi-asserted-by":"crossref","first-page":"eabe0013","DOI":"10.1126\/sciadv.abe0013","article-title":"Massive clonal expansion of polycytotoxic skin and blood CD8+ T cells in patients with toxic epidermal necrolysis","volume":"7","author":"Villani","year":"2021","journal-title":"Sci Adv"},{"issue":"2","key":"10.1016\/j.curtheres.2024.100767_bib0010","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/jid.2012.330","article-title":"TNF-\u03b1 and IFN-\u03b3 are potential inducers of Fas-mediated keratinocyte apoptosis through activation of inducible nitric oxide synthase in toxic epidermal necrolysis","volume":"133","author":"Viard-Leveugle","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.curtheres.2024.100767_bib0011","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.jid.2017.05.022","article-title":"Cyclosporine use in epidermal necrolysis is associated with an important mortality reduction: evidence from three different approaches","volume":"137","author":"Gonz\u00e1lez-Herrada","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.curtheres.2024.100767_bib0012","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/jamadermatol.2016.5668","article-title":"Systemic immunomodulating therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"153","author":"Zimmermann","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.curtheres.2024.100767_bib0013","doi-asserted-by":"crossref","first-page":"628","DOI":"10.25259\/IJDVL_605_19","article-title":"Comparison of effectiveness of interventions in reducing mortality in patients of toxic epidermal necrolysis: a network meta-analysis","volume":"87","author":"Patel","year":"2021","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"10.1016\/j.curtheres.2024.100767_bib0014","article-title":"Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS\/TEN overlap syndrome","volume":"3","author":"Jacobsen","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.curtheres.2024.100767_bib0015","doi-asserted-by":"crossref","first-page":"e19431","DOI":"10.1097\/MD.0000000000019431","article-title":"Fatal pediatric Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis","volume":"99","author":"Shi","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.curtheres.2024.100767_bib0016","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/cup.12894","article-title":"Microbiological findings and antibacterial therapy in Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis patients from a Swedish Burn Center","volume":"44","author":"Tocco-Tussardi","year":"2017","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.curtheres.2024.100767_bib0017","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1182\/bloodadvances.2023011658","article-title":"Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation","volume":"8","author":"Frerichs","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.curtheres.2024.100767_bib0018","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.3390\/ijerph20032217","article-title":"Multidisciplinary treatment in toxic epidermal necrolysis","volume":"20","author":"Surowiecka","year":"2023","journal-title":"Int J Environ Res Public Health"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X24000377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X24000377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T08:41:33Z","timestamp":1754642493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X24000377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":18,"alternative-id":["S0011393X24000377"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2024.100767","relation":{},"ISSN":["0011-393X"],"issn-type":[{"type":"print","value":"0011-393X"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral Cyclosporine Treatment for Four Pediatric Patients With Toxic Epidermal Necrolysis That Showed No Response to High-dose Corticosteroids in Combination With Intravenous Immunoglobulin: A Case Series","name":"articletitle","label":"Article Title"},{"value":"Current Therapeutic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.curtheres.2024.100767","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100767"}}